Congress Targets Chinese Companies and Officials with New Sanctions to Stop Fentanyl Trafficking
The House passed this bill in September 2025 and sent it to the Senate for review. Nothing has happened with the bill since September 2025, which is a period of 10 months. The Senate must now decide whether to take action, but it is common for bills to stall at this stage.
No action since September 2025
This bill’s path across every version that has carried it.
Reintroduced
Reintroduced from H.R. 3203 (118th), which died when its Congress ended.
H.R. 3203 (118th) →Scores run from -100 (strongly harmful) to +100 (strongly beneficial) for each group, combining impact, certainty, scope, and duration ratings of 1-5. How impact scoring works
U.S. businesses that import chemicals or materials from Chinese companies could face disruptions if their suppliers are sanctioned under this law. The bill explicitly excludes sanctions on the importation of goods (like manufactured products), but companies that rely on Chinese chemical suppliers for legitimate purposes may need to verify their supply chains. This creates some compliance burden but also protects legitimate trade.
Received in the Senate and Read twice and referred to the Committee on Banking, Housing, and Urban Affairs.
Sent to a congressional committee for expert review. The committee decides whether this bill moves forward.
Motion to reconsider laid on the table Agreed to without objection.
On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 407 - 4 (Roll no. 220). (text: CR H3728-3729)
The House fast-tracked this bill — limited debate, no amendments allowed, but needs two-thirds support to pass.
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 407 - 4 (Roll no. 220).
The House fast-tracked this bill — limited debate, no amendments allowed, but needs two-thirds support to pass.
Considered as unfinished business. (consideration: CR H3741-3742)
On Motion to Suspend the Rules and Pass, as Amended
Senator Steve Daines, a close ally of President Trump, met with Chinese officials to demand a halt to fentanyl ingredient exports before trade talks resume. The discussion highlights the legislative and diplomatic push to use sanctions and tariffs as leverage against Chinese chemical producers.
The House overwhelmingly passed the Stop Chinese Fentanyl Act of 2025, which allows for the designation of Chinese chemical companies as foreign opioid traffickers if they fail to cooperate with U.S. law enforcement. The bill received broad bipartisan support with a 407-4 vote.
As lawmakers return from recess, the House is prioritizing the Stop Chinese Fentanyl Act. The legislation is part of a broader 'China Week' strategy intended to punish Beijing for its perceived failure to stop the flow of precursor chemicals used by Mexican cartels.
No related bills recorded for this bill yet.
Document Type
Congressional Bill
Official Title
Stop Chinese Fentanyl Act of 2025
Analysis generated by AI. Always verify with official sources.